Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 650x65px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5498 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 53 54 55  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
PerkinElmer–Max Planck: silicon photomultiplier technology, 200908– license excl from Max Planck Innovation for SiPM developed by MPI-MPP + MEPhI 2009-08-18
Saarland Univ–GeneBio: SmileMS s/w, 200908– supply + collab SmileMS used w Thermo LXQ to create LC-MS mass spectral library by Prof H Maurer 2009-08-01
Rapid Micro Biosystems–TVM Capital: investment, 200907 financing round Series A totalling $18.6m incl investor TVM Capital 2009-07-08
Intana Bioscience–High-Tech Gründerfonds: investment, 200907 financing round totalling €650k incl High-Tech Gründerfonds 2009-07-06
Addex–TVM: investment, 200907 existent current public portfolio company of TVM 2009-07-01
Evotec–TVM: investment, 200907 existent current public portfolio company of TVM 2009-07-01
F-Star–TVM: investment, 200907 existent current private portfolio company of TVM 2009-07-01
GPC–TVM: investment, 200907 existent current public portfolio company of TVM 2009-07-01
invendo medical–TVM: investment, 200907 existent current private portfolio company of TVM 2009-07-01
Medigene–TVM: investment, 200907 existent current public portfolio company of TVM 2009-07-01
NatuTec–eBioscience: investment, 200907 acquisition of NatuTec GmbH by eBioscience Inc 2009-07-01
Nitec Pharma–TVM: investment, 200907 existent current private portfolio company of TVM 2009-07-01
Noxxon–TVM: investment, 200907 existent current private portfolio company of TVM 2009-07-01
Probiodrug–TVM: investment, 200907 existent current private portfolio company of TVM 2009-07-01
Riemser–TVM: investment, 200907 existent current private portfolio company of TVM 2009-07-01
Vivendy Therapeutics–TVM: investment, 200907 existent current private portfolio company of TVM 2009-07-01
Wilex–TVM: investment, 200907 existent current public portfolio company of TVM 2009-07-01
Symetis–SEVERAL: investment, 200906 financing round CHF23m co-led by Wellington Partners + Vinci Capital 2009-06-29
Evotec–Cellectricon: Dynaflow system, 200906 supply purchase Dynaflow electrophysiology system for ion channel screening by Evotec 2009-06-24
Evotec–MDS: cell analysis technology, 200906 supply existent use of IonWorks Quattro + PatchXpress for ion channel screening by Evotec 2009-06-24
Evotec–Nanion: cell analysis technology, 200906 supply existent use of Patchliner + Port-a-Patch systems for ion channel screening by Evotec 2009-06-24
Evotec–Sophion: QPatch system, 200906 supply purchase Q-Patch electrophysiology platform for ion channel screening by Evotec 2009-06-24
Korea Basic Science Institute–Australian National Univ: mass spectrometer, 200906 supply installation SHRIMP IIe HR-SIMS from ASI 2009-06-01
Max Planck–Inventive Capital: financial services, 200905 service development of DDC Ventures fund by MP Innovation + Inventive Capital Advisors LLP 2009-05-14
Max Planck–Life Sciences Partners: financial services, 200905– service management of DDC Ventures fund by LSP 2009-05-14
Panatecs–CovalX: mass spectrometry, 200905– supply Panatecs to offer MALDI-TOF proteomic services using High-Mass System from CovalX 2009-05-08
Renovis–Evotec: investment, 200905 DIVESTMENT shut down of Renovis + Evotec US operations 2009-05-05
Fresenius–Trion Pharma: catumaxomab, 200712 collab existent drug registration + marketing of Removab by Fresenius Biotech 2009-04-23
Miacom Diagnostics–Inveni Capital: investment, 200904 investment by Inveni Capital 2009-04-17
Sony–iCyt: flow cytometry, 200904– collab development of new flow cytometry device 2009-04-01
Mologen–SEVERAL: investment, 200903 capital increase €2.8m 425k new shares €6.5/share to institutional investors 2009-03-27
Panatecs–Germany (govt): investment, 200903 financing round totalling €5m KfW Mittelstandsbank + Zukunftsfonds Heilbronn 2009-03-26
Panatecs–Zukunftsfonds Heilbronn: investment, 200903 financing round totalling €5m KfW Mittelstandsbank + Zukunftsfonds Heilbronn 2009-03-26
Atheso Arzneimittelsicherheit–NONE: investment, 200903–201007 bankruptcy Local Court Hanover IN 187/09 2009-03-03
Anagnostics–Niederösterreich (govt): investment, 200902 financing round totalling €3m incl VC equity from tecnet equity 2009-02-27
Microstim–High-Tech Gründerfonds: investment, 200902 investment €500k by HTGF 2009-02-05
Nanonis–SPECS (DE): investment, 200901 acquisition Nanonis to be renamed SPECS Zurich GmbH 2009-01-30
HiperScan–High-Tech Gründerfonds: investment, 200901 equity investment €500k by HTGF 2009-01-19
Merck (DE)–Apitope: ATX-MS-1467, 200901– license excl ww developm + commercialisation to Merck Serono 2009-01-13
Bayer–Performance Plants: YPT technology, 2009– license research + commercial for use in cotton for Bayer CropScience 2009-01-01
Bayer–Tsinghua Univ: drug discovery, 2009– collab establishment of Bayer-Tsinghua Joint Research Center for Innovative Drug Discovery 2009-01-01
BMS–Qiagen: molecular companion diagnostics, 2009– collab incl therascreen KRAS RGQ PCR Kit for Erbitux 2009-01-01
EndoSense–LCF Rothschild: investment, 2009 investment in EndoSense by Edmond de Rothschild Investment Partners 2009-01-01
FORTH–Thermo Fisher: mass spectrometer, 2009 supply purchase LTQ-Orbitrap XL with ETD by Proteomics Facility of IMBB-FORTH 2009-01-01
GeneBio–Swiss Institute of Bioinformatics: neXtProt knowledge platform, 20090– collab development 2009-01-01
GlycoVaxyn–LCF Rothschild: investment, 2009 investment in GlycoVaxyn by Edmond de Rothschild Investment Partners 2009-01-01
JnJ–Cenix BioScience: siRNA technology, 2009– collab improvement of siRNA-based target validation methodologies Janssen Pharmaceutica NV 2009-01-01
Kolltan–Celtic Therapeutics: investment, 2009 acquisition of minority share in Kolltan Pharmaceuticals Inc 2009-01-01
Merck (DE)–Compugen: biomarker, 2009 collab discovery of biomarker signatures for drug induced toxicity Merck Serono 2009-01-01
Merck (DE)–Compugen: biomarker, 201206 collab founding joint venture Neviah Genomics with funding from Merck + technology from Compugen 2009-01-01
Novartis–Nuevolution: drug discovery services, 2009– service using Chemetics technology to discover compounds against Novartis targets 2009-01-01
Novartis–Nuevolution: drug discovery technology, 201401– collab + non-excl licencse €na for using Chemetics technology with + within Novartis 2009-01-01
Spirogen–Celtic Therapeutics: investment, 2009 acquisition of majority share in Spirogen Ltd 2009-01-01
European Biotechnology Foundation–Biocom: investment, –200812–200912– existent Biocom AG owns 100% of EFB 2008-12-31
Phytolutions–Bremen (govt): grant, 200812–201012 grant €250k for pilot project algae biofuel production from WFB Bremen within PFAU programme 2008-12-15
Max Planck–Proxeon: EASY-nLC, 200811 supply MPI for Biochemisty Mann Group to standardise LC/MS on EASY-nLC 2008-11-11
Helsinn–Zealand Pharma: GLP-2 peptide agonist, 200811–201706 license ww excl to elsiglutide €140m milestones + royalties RIGHTS RETURNED 6/17 2008-11-01
Phenex–SEVERAL: investment, 200810 financing round €8.2m lead investor LBBW Venture 2008-10-02
Axicorp–Biocon: investment, 200810 acquisition 70% for €30m 2008-10-01
Kirin–Kyowa Hakko Kogyo: investment, 200810 merger of Kirin Pharma + Kyowa Hakko Kogyo into Kyowa Hakko Kirin 2008-10-01
Univ Applied Sciences Bremen–Bremen (govt): grant, 200810–201109 grant €68k for developm nucleases for molecular analytics WFB RnD Innovation Progr 2008-10-01
Telormedix–College Group: public relations, 200809–201109– service existent by College Hill Life Sciences 2008-09-30
Telormedix–SEVERAL: investment, 200809 financing round Series A CHF21m=€13.1m=$19m led by Aravis Venture 2008-09-30
Ciba Spezialitätenchemie–BASF: investment, 200809–200904 acquisition 2008-09-01
Merck (DE)–Ablynx: Nanobodies, 200809– collab co-discovery + co-developm Nanobodies against two targets in immunology + oncology Merck Serono 2008-09-01
Allianz–Commerzbank: investment, 200808– acquisition €9.8b of Dresdner Bank AG by Commerzbank AG 2008-08-31
Denali Therapeutics–Evotec: CNS drug discovery, 201608 strategic collab existent 2008-08-25
Denali Therapeutics–Roche: LRRK2 inhibitors, 201608 license ww excl existent to develop + commericalize LRRK2 inhibitors from Genentech 2008-08-25
S.I.S. Surface Imaging Systems–Bruker: investment, 200808 acquisition €na by Bruker AXS to be renamed Bruker Nano GmbH 2008-08-18
Novartis–Cytos Biotechnology: Alzheimer vaccine, 200807 collab existent for CAD106 2008-07-24
Ipsogen–NewCap: public relations, 200806 service existent 2008-06-30
Mercachem–Proteros: drug discovery services, 200806– collab joint offering of services to life science industry 2008-06-23
Phytolutions–Jacobs Univ: investment, 200806 founding investors are JCBS Holding GmbH + Claudia Thomsen + Stefan Rill 2008-06-17
Phytolutions–PERSON: investment, 200806 founding investors are JCBS Holding GmbH + Claudia Thomsen + Stefan Rill 2008-06-17
Pieris–Novo Group: investment, 200803 financing round Series B totalling €25m incl lead investors OrbiMed Adivsors + Novo Nordisk Biotech Fund 2008-03-27
Pieris–OrbiMed: investment, 200803 financing round Series B totalling €25m incl lead investors OrbiMed Adivsors + Novo Nordisk Biotech Fund 2008-03-27
SeQuant–Merck (DE): investment, 200802 acquisition of SeQuant AB renamed Merck SeQuant AB 2008-02-29
GSG Mess- und Analysengeräte–LECO: mass spectrometer, 200802– distribution excl of Unique LC-TOF-MS system in DE + AT + CH by GSG 2008-02-11
Applera–CovalX: mass spectrometry, 200801– collab product integration to retrofit ABI MALDI TOFs with CovalX HM1 High-Mass System 2008-01-22
Minapharm–Artes Biotechnology: rec protein production, 200801– collab €na use of Hansenula technology to develop 3 therapeutic proteins 2008-01-14
Abimed–Kinesis: investment, 200801 acquisition 2008-01-01
Bayer–BioInvent: antibody library, 2008 license to n-CoDeR libraries for development of therapeutic antibodies 2008-01-01
BioNTech–SEVERAL: investment, 2008 seed financing round 2008-01-01
Boehringer–Beactica: drug discovery services, 2008– collab fragment-based drug discovery services for oncology-relevant kinases 2008-01-01
Corimmun–SEVERAL: investment, 2008 financing round Series A led by MIG AG 2008-01-01
F-Star–TVM: investment, 2008 initial investment of TVM 2008-01-01
Genentech–Symphogen: therapeutic antibodies, 200806– collab up to >$330m discovery + developm incl Symplex + Sympress technologies 2008-01-01
GUARDED project–EU (govt): grant, 200801–201012 funding €3.5m from European Defense Agency as JIP-FP project 2008-01-01
GUARDED project–Ionicon: PTR-MS, 200801–201012 collab Ionicon is project partner developing rugged + compact PTR-MS instrument 2008-01-01
invendo medical–TVM: investment, 2008 initial investment of TVM 2008-01-01
Isoprime–Elementar: investment, 2008 acquisition of Isoprime Ltd by Elementar Analysensysteme GmbH 2008-01-01
Luphos–High-Tech Gründerfonds: investment, 2008 1st financing round with HTGF 2008-01-01
Nitec Pharma–TVM: investment, 2008 initial investment of TVM 2008-01-01
Riemser–TVM: investment, 2008 initial investment of TVM 2008-01-01
Symphogen–Genentech: investment, 200806 equity investment in connection with collaboration agreement 2008-01-01
Vivendy Therapeutics–TVM: investment, 2008 initial investment of TVM 2008-01-01
Korea Basic Science Institute–Bruker BioSciences: mass spectrometer, 200712 supply installation world¹s first 15 Tesla ESI/MALDI FT-ICR MS 2007-12-01
Caprotec–Berlin (govt): investment, 200711–200801 seed financing round totalling €6m incl investor VC Fonds Berlin GmbH 2007-11-22
Caprotec–Creathor Ventures: investment, 200711–200801 seed financing round totalling €6m incl investor Creathor Venture 2007-11-22
Ecron–Manipal: investment, 200711 merger acquisition of Ecron GmbH by Manipal AcuNova Ltd 2007-11-05
next pagenext page 1 2 3 ... 53 54 55  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px

» top